SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers-Reference-Cited by-同舟云学术

SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers

Published:2018-09 Issue: Volume:266 Page:128-132
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Amin Ahmad S.,Reckman Yolan J.,Arbelo Elena,Spanjaart Anne M.,Postema Pieter G.,Tadros Rafik,Tanck Michael W.,Van den Berg Maarten P.,Wilde Arthur A.M.,Tan Hanno L.

Funder

Netherlands Heart Foundation

Netherlands CardioVascular Research Initiative

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy;Kakisita;J. Am. Coll. Cardiol.,2000

2. Flecainide test in Brugada syndrome: a reproducible but risky tool;Gasparini;Pacing Clin. Electrophysiol.,2003

3. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease;Zhang;Am. J. Physiol. Heart Circ. Physiol.,2007

4. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies;Meregalli;Heart Rhythm.,2009

5. Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome;Le Scouarnec;Hum. Mol. Genet.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic analysis of SCN5A variants associated with inherited cardiac diseases;Heart Rhythm;2024-08

2. SCN5A-L256del and L1621F exhibit loss-of-function properties related to autosomal recessive congenital cardiac disorders presenting as sick sinus syndrome, dilated cardiomyopathy, and sudden cardiac death;Gene;2024-03

3. The opioid tramadol blocks the cardiac sodium channel Nav1.5 in HEK293 cells;Europace;2023-07-12

4. Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome;European Heart Journal;2023-06-22

5. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry);Circulation;2023-05-23